THE IMPROVE TRIAL: Improving Pain Management and Outcomes With Various Strategies of Patient-Controlled Analgesia (PCA) (IMPROVE)

This study has been terminated.
(Inability to meet target enrollment prior to ending of network in March 2011.)
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
New England Research Institutes
ClinicalTrials.gov Identifier:
NCT00999245
First received: October 20, 2009
Last updated: April 16, 2013
Last verified: April 2013